These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9607426)

  • 1. Role of 131I-metaiodobenzylguanidine in the treatment of neuroblastoma.
    Mastrangelo R; Tornesello A; Mastrangelo S
    Med Pediatr Oncol; 1998 Jul; 31(1):22-6. PubMed ID: 9607426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of advanced neuroblastoma in children over 1 year of age: the critical role of ¹³¹I-metaiodobenzylguanidine combined with chemotherapy in a rapid induction regimen.
    Mastrangelo S; Rufini V; Ruggiero A; Di Giannatale A; Riccardi R
    Pediatr Blood Cancer; 2011 Jul; 56(7):1032-40. PubMed ID: 21344615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined use of chemotherapy and 131I-metaiodobenzylguanidine in the treatment of advanced-stage neuroblastoma.
    Sari O; Uğur O; Emir S; Akyüz C
    Turk J Pediatr; 2001; 43(1):29-33. PubMed ID: 11297155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodine-131-meta-iodobenzylguanidine therapy for patients with newly diagnosed high-risk neuroblastoma.
    Kraal KC; van Dalen EC; Tytgat GA; Van Eck-Smit BL
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010349. PubMed ID: 28429876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility, toxicity and response of upfront metaiodobenzylguanidine therapy therapy followed by German Pediatric Oncology Group Neuroblastoma 2004 protocol in newly diagnosed stage 4 neuroblastoma patients.
    Kraal KC; Bleeker GM; van Eck-Smit BL; van Eijkelenburg NK; Berthold F; van Noesel MM; Caron HN; Tytgat GA
    Eur J Cancer; 2017 May; 76():188-196. PubMed ID: 28329731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second malignancies in children with neuroblastoma after combined treatment with 131I-metaiodobenzylguanidine.
    Garaventa A; Gambini C; Villavecchia G; Di Cataldo A; Bertolazzi L; Pizzitola MR; De Bernardi B; Haupt R
    Cancer; 2003 Mar; 97(5):1332-8. PubMed ID: 12599242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of molecular radiotherapy with [131I]-meta Iodobenzylguanidine for high-risk neuroblastoma.
    Gaze MN; Gains JE; Walker C; Bomanji JB
    Q J Nucl Med Mol Imaging; 2013 Mar; 57(1):66-78. PubMed ID: 23474636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary ovarian insufficiency in children after treatment with 131I-metaiodobenzylguanidine for neuroblastoma: report of the first two cases.
    Clement SC; Kraal KC; van Eck-Smit BL; van den Bos C; Kremer LC; Tytgat GA; van Santen HM
    J Clin Endocrinol Metab; 2014 Jan; 99(1):E112-6. PubMed ID: 24187404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma.
    Yanik GA; Levine JE; Matthay KK; Sisson JC; Shulkin BL; Shapiro B; Hubers D; Spalding S; Braun T; Ferrara JL; Hutchinson RJ
    J Clin Oncol; 2002 Apr; 20(8):2142-9. PubMed ID: 11956276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted radiotherapy with submyeloablative doses of 131I-MIBG is effective for disease palliation in highly refractory neuroblastoma.
    Kang TI; Brophy P; Hickeson M; Heyman S; Evans AE; Charron M; Maris JM
    J Pediatr Hematol Oncol; 2003 Oct; 25(10):769-73. PubMed ID: 14528098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of neuroblastoma with [131I]MIBG at diagnosis.
    Troncone L; Rufini V; Luzi S; Mastrangelo R; Riccardi R
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):65-8. PubMed ID: 9002753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 131I-Metaiodobenzylguanidine therapy in children with advanced neuroblastoma.
    DuBois SG; Matthay KK
    Q J Nucl Med Mol Imaging; 2013 Mar; 57(1):53-65. PubMed ID: 23474635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric 131I-MIBG Therapy for Neuroblastoma: Whole-Body 131I-MIBG Clearance, Radiation Doses to Patients, Family Caregivers, Medical Staff, and Radiation Safety Measures.
    Willegaignon J; Crema KP; Oliveira NC; Pelissoni RA; Coura-Filho GB; Sapienza MT; Buchpiguel CA
    Clin Nucl Med; 2018 Aug; 43(8):572-578. PubMed ID: 29916922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 131I-MIBG followed by consolidation with busulfan, melphalan and autologous stem cell transplantation for refractory neuroblastoma.
    French S; DuBois SG; Horn B; Granger M; Hawkins R; Pass A; Plummer E; Matthay K
    Pediatr Blood Cancer; 2013 May; 60(5):879-84. PubMed ID: 23024113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroblastoma therapy using radiolabelled [131I]meta-iodobenzylguanidine ([131I]MIBG) in combination with other agents.
    Mairs RJ
    Eur J Cancer; 1999 Aug; 35(8):1171-3. PubMed ID: 10615225
    [No Abstract]   [Full Text] [Related]  

  • 16. [Radio iodized metaiodobenzylguanidine (MIBG) in the treatment of neuroblastoma: modalities and indications].
    Défachelles AS; Cougnenc O; Carpentier P
    Bull Cancer; 2011 May; 98(5):559-69. PubMed ID: 21609890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial.
    Matthay KK; Weiss B; Villablanca JG; Maris JM; Yanik GA; Dubois SG; Stubbs J; Groshen S; Tsao-Wei D; Hawkins R; Jackson H; Goodarzian F; Daldrup-Link H; Panigrahy A; Towbin A; Shimada H; Barrett J; Lafrance N; Babich J
    J Nucl Med; 2012 Jul; 53(7):1155-63. PubMed ID: 22700000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [131I]MIBG as a first line treatment in advanced neuroblastoma.
    Hoefnagel CA; De Kraker J; Valdés Olmos RA; Voûte PA
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):61-4. PubMed ID: 9002752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma.
    Mastrangelo S; Tornesello A; Diociaiuti L; Riccardi R; Rufini V; Troncone L
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):69-71. PubMed ID: 9002754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age.
    de Kraker J; Hoefnagel KA; Verschuur AC; van Eck B; van Santen HM; Caron HN
    Eur J Cancer; 2008 Mar; 44(4):551-6. PubMed ID: 18267358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.